Iovance Biotherapeutics, Inc.
IOVA
$3.89
-$0.15-3.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.28% | -24.32% | -26.99% | 0.99% | 15.69% |
| Total Receivables | 18.90% | 19.71% | 89.65% | 30,215.38% | 45,820.53% |
| Inventory | 0.31% | 34.04% | 78.91% | 272.06% | 396.72% |
| Prepaid Expenses | -6.42% | 45.57% | 13.39% | 38.37% | -29.10% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.14% | -13.94% | -12.39% | 32.97% | 48.46% |
|
|
|||||
| Total Current Assets | -3.14% | -13.94% | -12.39% | 32.97% | 48.46% |
| Net Property, Plant & Equipment | 7.75% | -2.15% | -4.25% | -11.36% | -6.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.09% | -6.99% | 0.32% | -3.04% | 23.18% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 110.26% | 129.63% | 143.33% | -6.59% | -89.91% |
| Total Assets | 0.30% | -8.69% | -5.90% | 11.14% | 16.67% |
|
|
|||||
| Total Accounts Payable | -19.45% | -1.42% | 56.76% | 10.85% | -16.95% |
| Total Accrued Expenses | 39.26% | 13.94% | 29.87% | 73.06% | 12.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -60.89% | -36.97% | -29.43% | -14.25% | 65.82% |
| Total Finance Division Other Current Liabilities | -4.46% | 112.26% | 553.11% | 334.56% | 176.90% |
| Total Other Current Liabilities | -4.46% | 112.26% | 553.11% | 334.56% | 176.90% |
| Total Current Liabilities | 13.09% | 6.55% | 37.93% | 47.44% | 10.91% |
|
|
|||||
| Total Current Liabilities | 13.09% | 6.55% | 37.93% | 47.44% | 10.91% |
| Long-Term Debt | -- | -- | -- | -- | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.08% | -31.90% | -34.88% | -38.83% | -33.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.51% | -1.71% | 8.78% | -4.02% | 86.29% |
| Total Liabilities | 7.28% | -6.89% | 6.73% | 4.78% | 2.19% |
|
|
|||||
| Common Stock & APIC | 11.68% | 10.66% | 10.02% | 16.29% | 19.33% |
| Retained Earnings | -16.40% | -17.24% | -17.54% | -17.66% | -18.49% |
| Treasury Stock & Other | 1,671.70% | -0.86% | 3,865.59% | 5,325.86% | -141.41% |
| Total Common Equity | -1.66% | -9.20% | -9.11% | 12.92% | 21.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -33.33% | -33.33% | -33.33% | -33.33% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -33.33% | -33.33% | -33.33% | -33.33% | 0.00% |
|
|
|||||
| Total Common Equity | -1.66% | -9.20% | -9.11% | 12.92% | 21.52% |
| Total Preferred Equity | -33.33% | -33.33% | -33.33% | -33.33% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.66% | -9.20% | -9.11% | 12.92% | 21.52% |
|
|
|||||